Trial intelligence / Profile preview

Ondansetron versus dexamethasone for prevention of post-spinal anesthesia headache after elective cesarean section

IRCT20170802035464N2Phase 3Completed

Sponsor
Arak University of Medical Sciences
Start
Jun 2017
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in post-dural puncture headache (PDPH) comparing Ondansetron, Dexamethasone and Placebo (3 arms). Primary endpoints: Headache intensity at 12 hours, Headache intensity at 24 hours and 1 more. Started Jun 2017; status: completed.

02

Drugs

ondansetrondexamethasone
03

Conditions

post-dural puncture headache (PDPH)

Beyond the preview

Go deeper on IRCT20170802035464N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20170802035464N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call